Patterns of failure after radical surgery among patients with thoracic esophageal squamous cell carcinoma: implications for the clinical target volume design of postoperative radiotherapy

Qi Liu, Xu-Wei Cai, Bin Wu, Zheng-Fei Zhu, Hai-Quan Chen, Xiao-Long Fu, Qi Liu, Xu-Wei Cai, Bin Wu, Zheng-Fei Zhu, Hai-Quan Chen, Xiao-Long Fu

Abstract

Background: This study evaluated patterns of treatment failure (especially locoregional failure; LRF) after radical esophagectomy and proposes a clinical target volume (CTV) for postoperative radiotherapy (PORT) among patients with thoracic esophageal squamous cell carcinoma (SCC).

Methods: All patients who were followed up in our center after radical esophagectomy between 2007 and 2011 were retrospectively enrolled. The patterns of first discovered failure were assessed, and LRFs (including anastomotic and regional lymph node recurrences) were evaluated to determine whether our proposed PORT CTV encompassed these areas. The clinicopathologic factors predictive of lymphatic recurrence type were analyzed.

Results: Of the 414 patients who underwent surgery and were followed up over the study, 207 experienced recurrent or metastatic diseases. The median time to progression was 11.0 months. Of the 173 patients with locoregional recurrence, nodal failure recurred in 160; supraclavicular and superior mediastinal lymph nodes had the highest metastasis rates. All 233 recurrent sites across the 160 patients were located in a standard CTV area, including the bilateral supraclavicular areas, the entire mediastinum, and the left gastric lymphatic drainage region. A total of 203 sites (87.2%) were located in either the bilateral supraclavicular areas or the entire mediastinum, and 185 sites (79.4%) were located in either the bilateral supraclavicular areas or the upper mediastinum. A multivariate analysis revealed the lymph node metastatic ratio (LNMR) and tumor differentiation were risk factors for nodal failure.

Conclusions: Locoregional recurrence (especially lymph node recurrence) was the most common and potentially preventable type of initial treatment failure after curative surgery among patients with thoracic esophageal SCC. The proposed PORT CTV covered most LRF sites. The lymphatic drainage regions for PORT are selective, and the supraclavicular and superior mediastinal areas should be considered. However, the value of PORT and the extent of CTV should be investigated in further prospective studies.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Definition of the lymph node…
Figure 1. Definition of the lymph node regions.
Figure 2. The number of recurrent sites…
Figure 2. The number of recurrent sites located based on CT landmarks.

References

    1. Mirinezhad SK, Somi MH, Seyednezhad F, Jangjoo AG, Ghojazadeh M, et al. (2013) Survival in patients treated with definitive chemo-radiotherapy for non-metastatic esophageal cancer in north- west iran. Asian Pac J Cancer Prev 14: 1677–1680.
    1. Nakagawa S, Kanda T, Kosugi S, Ohashi M, Suzuki T, et al. (2004) Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy. J Am Coll Surg 198: 205–211.
    1. Chen G, Wang Z, Liu XY, Liu FY (2007) Recurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified Ivor-Lewis esophagectomy. World J Surg 31: 1107–1114.
    1. van Hagen P, Wijnhoven BP, Nafteux P, Moons J, Haustermans K, et al. (2013) Recurrence pattern in patients with a pathologically complete response after neoadjuvant chemoradiotherapy and surgery for oesophageal cancer. Br J Surg 100: 267–273.
    1. van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge HM, et al. (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366: 2074–2084.
    1. Rice TW, Adelstein DJ, Chidel MA, Rybicki LA, DeCamp MM, et al. (2003) Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma. J Thorac Cardiovasc Surg 126: 1590–1596.
    1. Xiao ZF, Yang ZY, Miao YJ, Wang LH, Yin WB, et al. (2005) Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases. Int J Radiat Oncol Biol Phys 62: 82–90.
    1. Chen J, Pan J, Zheng X, Zhu K, Li J, et al. (2012) Number and location of positive nodes, postoperative radiotherapy, and survival after esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 82: 475–482.
    1. Xu Y, Liu J, Du X, Sun X, Zheng Y, et al. (2013) Prognostic impact of postoperative radiation in patients undergoing radical esophagectomy for pathologic lymph node positive esophageal cancer. Radiat Oncol 8: 116.
    1. Schreiber D, Rineer J, Vongtama D, Wortham A, Han P, et al. (2010) Impact of postoperative radiation after esophagectomy for esophageal cancer. J Thorac Oncol 5: 244–250.
    1. Japanese Society for Esophageal Diseases. (2001) Guidelines for clinical and pathologic studies on carcinoma of the esophagus, 9 ed. Tokyo: Kanehara & Co, Ltd.
    1. Lee SJ, Lee KS, Yim YJ, Kim TS, Shim YM, et al. (2005) Recurrence of squamous cell carcinoma of the oesophagus after curative surgery: rates and patterns on imaging studies correlated with tumour location and pathological stage. Clin Radiol 60: 547–554.
    1. Cai WJ, Xin PL (2010) Pattern of relapse in surgical treated patients with thoracic esophageal squamous cell carcinoma and its possible impact on target delineation for postoperative radiotherapy. Radiother Oncol 96: 104–107.
    1. Li CL, Zhang FL, Wang YD, Han C, Sun GG, et al. (2013) Characteristics of recurrence after radical esophagectomy with two-field lymph node dissection for thoracic esophageal cancer. Oncol Lett 5: 355–359.
    1. Teniere P, Hay JM, Fingerhut A, Fagniez PL (1991) Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. French University Association for Surgical Research. Surg Gynecol Obstet 173: 123–130.
    1. Fok M, Sham JS, Choy D, Cheng SW, Wong J (1993) Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery 113: 138–147.
    1. Zieren HU, Muller JM, Jacobi CA, Pichlmaier H, Muller RP, et al. (1995) Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus: a prospective randomized study. World J Surg 19: 444–449.
    1. Tachibana M, Kinugasa S, Shibakita M, Tonomoto Y, Hattori S, et al. (2006) Surgical treatment of superficial esophageal cancer. Langenbecks Arch Surg 391: 304–321.
    1. Chen J, Liu S, Pan J, Zheng X, Zhu K, et al. (2009) The pattern and prevalence of lymphatic spread in thoracic oesophageal squamous cell carcinoma. Eur J Cardiothorac Surg 36: 480–486.
    1. Huang W, Li B, Gong H, Yu J, Sun H, et al. (2010) Pattern of lymph node metastases and its implication in radiotherapeutic clinical target volume in patients with thoracic esophageal squamous cell carcinoma: A report of 1077 cases. Radiother Oncol 95: 229–233.
    1. Qiao XY, Wang W, Zhou ZG, Gao XS, Chang JY (2008) Comparison of efficacy of regional and extensive clinical target volumes in postoperative radiotherapy for esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 70: 396–402.
    1. Lu JC, Tao H, Zhang YQ, Zha WW, Qian PD, et al. (2008) Extent of prophylactic postoperative radiotherapy after radical surgery of thoracic esophageal squamous cell carcinoma. Dis Esophagus 21: 502–507.
    1. Yu E, Tai P, Younus J, Malthaner R, Truong P, et al. (2009) Postoperative extended-volume external-beam radiation therapy in high-risk esophageal cancer patients: a prospective experience. Curr Oncol 16: 48–54.
    1. Bhansali MS, Fujita H, Kakegawa T, Yamana H, Ono T, et al. (1997) Pattern of recurrence after extended radical esophagectomy with three-field lymph node dissection for squamous cell carcinoma in the thoracic esophagus. World J Surg 21: 275–281.
    1. Kimura H, Konishi K, Arakawa H, Oonishi I, Kaji M, et al. (1999) Number of lymph node metastases influences survival in patients with thoracic esophageal carcinoma: therapeutic value of radiation treatment for recurrence. Dis Esophagus 12: 205–208.
    1. Shridhar R, Imani-Shikhabadi R, Davis B, Streeter OA, Thomas Jr CR (2013) Curative Treatment of Esophageal Cancer:An Evidenced Based Review. J Gastrointest Canc 44: 375–384.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren